General
- A rare syndrome
- An autosomal dominant disorder
Clinical features
- Myxomas (cutaneous and cardiac)
- Spotty pigmentations
- Tumours
- Pituitary adenomas
- 10% have pituitary adenomas
- 75% of patients having subclinical elevation of GH, IGF- 1, and prolactin.
- Cushing syndrome associated with adrenal hyperplasia
- Acromegaly
- Schwannomas
- Psammomatous melanotic type arising from Schwann cells
- 10% of CNC cases
- Associated with Malignant melanotic nerve sheath tumour
Genetic features
- Heterogeneous
- Associated germline mutations include
- CNC1 loci at 17q22- 24
- Encodes protein kinase A regulatory subunit Ia (PRKAR1A)
- Normally PRKAR1A encodes the type 1A regulatory subunit of PKA → inhibiting PKA
- CNC causes a loss-of-function germline mutations of PRKAR1A → cannot inhibit PKA → increase PKA activity leading to increase in downstream pathway activation
- ERK
- TGF-beta
- WNT
- CNC1 loci at 2p16